Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Assessing chemokine co-receptor usage in HIV.

Coakley E, Petropoulos CJ, Whitcomb JM.

Curr Opin Infect Dis. 2005 Feb;18(1):9-15. Review.

PMID:
15647694
2.

HIV co-receptors as targets for antiviral therapy.

Schols D.

Curr Top Med Chem. 2004;4(9):883-93. Review.

PMID:
15134547
3.

Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.

Irlbeck DM, Amrine-Madsen H, Kitrinos KM, Labranche CC, Demarest JF.

AIDS. 2008 Jul 31;22(12):1425-31. doi: 10.1097/QAD.0b013e32830184ba.

PMID:
18614865
4.

Co-receptor antagonists as HIV-1 entry inhibitors.

Shaheen F, Collman RG.

Curr Opin Infect Dis. 2004 Feb;17(1):7-16. Review.

PMID:
15090884
5.

[Deep lung--cellular reaction to HIV].

Tavares Marques MA, Alves V, Duque V, Botelho MF.

Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Review. Portuguese.

PMID:
17492233
6.
7.

HIV-1 coreceptors and their inhibitors.

Ray N, Doms RW.

Curr Top Microbiol Immunol. 2006;303:97-120. Review.

PMID:
16570858
8.

CCR5 antagonists: host-targeted antivirals for the treatment of HIV infection.

Westby M, van der Ryst E.

Antivir Chem Chemother. 2005;16(6):339-54. Review.

PMID:
16329283
9.

Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists.

De Clercq E, Schols D.

Antivir Chem Chemother. 2001;12 Suppl 1:19-31.

PMID:
11594685
10.

Genotypic coreceptor analysis.

Sierra S, Kaiser R, Thielen A, Lengauer T.

Eur J Med Res. 2007 Oct 15;12(9):453-62. Review.

PMID:
17933727
11.

Determination of HIV-1 coreceptor tropism in clinical practise.

Foeglein A, Walter H.

Eur J Med Res. 2007 Oct 15;12(9):473-82. Review.

PMID:
17933729
12.

The epidemiology of HIV coreceptor tropism.

Hoffmann C.

Eur J Med Res. 2007 Oct 15;12(9):385-90. Review.

PMID:
17933718
13.

Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs.

Seibert C, Sakmar TP.

Curr Pharm Des. 2004;10(17):2041-62. Review.

PMID:
15279544
14.

Chemokine receptor-directed agents as novel anti-HIV-1 therapies.

Mills SG, DeMartino JA.

Curr Top Med Chem. 2004;4(10):1017-33. Review.

PMID:
15193136
15.

HIV chemokine receptor inhibitors as novel anti-HIV drugs.

Princen K, Schols D.

Cytokine Growth Factor Rev. 2005 Dec;16(6):659-77. Epub 2005 Jul 6. Review.

PMID:
16005254
16.
17.

CCR5 antagonists: a new tool in fighting HIV.

Jülg B, Goebel FD.

J HIV Ther. 2005 Dec;10(4):68-71. Review.

PMID:
16519245
18.

Current tests to evaluate HIV-1 coreceptor tropism.

Rose JD, Rhea AM, Weber J, Quiñones-Mateu ME.

Curr Opin HIV AIDS. 2009 Mar;4(2):136-42. doi: 10.1097/COH.0b013e328322f973. Review.

PMID:
19339953
19.

HIV-1 coreceptor usage, transmission, and disease progression.

Philpott SM.

Curr HIV Res. 2003 Apr;1(2):217-27. Review.

PMID:
15043204
20.

Susceptibility of diverse primary HIV isolates with varying co-receptor specificity's to CXCR4 antagonistic compounds.

Owen SM, Rudolph D, Schols D, Fujii N, Yamamoto N, Lal RB.

J Med Virol. 2002 Oct;68(2):147-55.

PMID:
12210401
Items per page

Supplemental Content

Write to the Help Desk